ZYDELIG
Identification of Zydelig
| No description |
Google image searchProduct monograph
Active ingredient
idelalisib, 150 MG
DIN: 02438801
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GILEAD SCIENCES CANADA INC
Date: 21-APR-2015
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EM — Phosphatidylinositol-3-kinase (Pi3K) inhibitors (ATC, ATC/DDD)
- L01EM01 — IDELALISIB (ATC/DDD)
Reference brand drug: Zydelig
